Sitemap
-
-
-
-
2023CPHI Barcinonensis |
Congregate ad novum capitulum |
Vires fabricandi praemisit|Jiangsu Runan Pharmaceutical Co.,LTD annui conventus & commendationis conventus |
2024CPHI Japan |
Praecipua exercitatio practica pro accidentibus lacus lacus in logistics societatis anno 2024 |
2023API Exhibition |
Oratio in Provectus Usus Exchange Conference of Jiangsu Runan Pharmaceutical on Enterprise Safety Production in Industrial Parks |
Comprehensiva practica ad productionem salutis accidentia in MMXXIII |
Notitia Approbatio pro Fusce Trials Classis 1 Medicamenta innovativa per Jiangsu Zhengda Qingjiang Pharmaceutical Co., Ltd. |
Jiangsu Run'an Pharmaceutical Co., Ltd. Salutis Productio Mensis Actio Summarium, Aestimatio, Praemium et Commendatio Notitia |
Jiangsu Runan Pharmaceutical recipit GMP inspectionem |
Confirma proprietatem intellectualem tutelam et creo amet agro |
Chen Zhichang, Secretarius Factionis Municipalis Committee, investigationes perduxit de constructione novae areae officinae Zhengda Qingjiang Pharmaceuticae. |
Nuntiatio Jiangsu Run'an Pharmaceutical Co., Ltd. ante MMXXIII Tersus Productio Audit |
Sodium nitroprussidum et urapidil, medicamenta antihypertensiva, diversas habent contraindicationes et motus adversas! |
Notae pharmacologicae dexmedetomidine eiusque applicatione in delirio postopertivo in aegros senes |
Quis efficacior est, Elamod vel Methotrexate
-
-
-
-